Combined surgical approach to carotid and coronary artery disease

Cristijan Bulat1, Igor Alfirević, Zvonimir Ante Korda

  • 1Department of Cardiovascular Surgery, Special Hospital for Cardiovascular Surgery and Cardiology Magdalena, Krapinske Toplice, Croatia. cristijan.bulat@zg.htnet.hr

Insights

Combined carotid endarterectomy and coronary artery bypass grafting (CEA/CABG) is safe and effective. Both cardiopulmonary bypass (CPB) and off-pump techniques showed no significant differences in neurological events or mortality.

Area of Science:

  • Cardiovascular Surgery
  • Neurology
  • Vascular Surgery

Background:

  • Coexistent carotid and coronary artery disease presents a complex surgical challenge.
  • Combined procedures aim to address both conditions simultaneously, but optimal technique remains debated.

Purpose of the Study:

  • To compare the safety and efficacy of combined carotid endarterectomy and coronary artery bypass grafting (CEA/CABG) using cardiopulmonary bypass (CPB) versus off-pump techniques.

Main Methods:

  • Thirty-five patients with severe carotid and coronary artery disease underwent combined CEA/CABG.
  • Patients were divided into two groups: one with CPB (arrested heart) and one off-pump (beating heart).
  • Outcomes including perioperative neurological events, mortality, and myocardial infarction were assessed.

Main Results:

  • No transient or permanent perioperative neurological events occurred in either group.
  • Early mortality was 5.6% and perioperative myocardial infarction was 5.5% across both groups.
  • No late strokes were observed during the follow-up period.

Conclusions:

  • Combined CEA/CABG is a safe and effective procedure for patients with severe, coexistent carotid and coronary artery disease.
  • Both CPB and off-pump techniques demonstrate comparable safety profiles regarding neurological and cardiac outcomes.
  • The choice between CPB and off-pump may not significantly impact early or late outcomes in this combined procedure.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...